Compare PCVX & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | NOV |
|---|---|---|
| Founded | 2013 | 1862 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.7B |
| IPO Year | 2020 | 1996 |
| Metric | PCVX | NOV |
|---|---|---|
| Price | $46.79 | $17.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 14 |
| Target Price | ★ $105.00 | $16.71 |
| AVG Volume (30 Days) | 1.1M | ★ 3.9M |
| Earning Date | 02-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | ★ $8,775,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.66 | $10.84 |
| 52 Week High | $93.77 | $18.22 |
| Indicator | PCVX | NOV |
|---|---|---|
| Relative Strength Index (RSI) | 52.91 | 66.43 |
| Support Level | $44.57 | $17.55 |
| Resistance Level | $49.55 | $18.22 |
| Average True Range (ATR) | 2.13 | 0.55 |
| MACD | 0.15 | 0.13 |
| Stochastic Oscillator | 52.90 | 89.87 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.